Venture capital
 Start-up success

Title: Commercialization Council venture news
Full Citation
Permanent Link: http://ufdc.ufl.edu/UF00088889/00001
 Material Information
Title: Commercialization Council venture news
Series Title: Commercialization Council venture news
Physical Description: Serial
Language: English
Creator: University of Florida Commercialization Council
Publisher: University of Florida Commercialization Council
Publication Date: March 2003
Subject: University of Florida.   ( lcsh )
Spatial Coverage: North America -- United States of America -- Florida
 Record Information
Bibliographic ID: UF00088889
Volume ID: VID00001
Source Institution: University of Florida
Holding Location: University of Florida
Rights Management: All rights reserved, Board of Trustees of the University of Florida


This item has the following downloads:

UFCC_March ( PDF )

Table of Contents
    Venture capital
        Page 1
        Page 2
        Page 3
    Start-up success
        Page 4
        Page 5
Full Text
Venture Newsletter

Commercialization Council



SC t aMrV r tne e uaC te n F iti t Su e f m e Piao o FB e T ho--

March 2003


V 1 EArI'T




Florida Venture Capital in the News

Corporate Leaders

Approximately 200 executives and prospective investors from the
pharmaceutical, biotechnology and related industries gathered at the
UF Hotel and Conference Center in Gainesville on February 21 for the
2003 Corporate Leaders Summit on Biotechnology, sponsored by the
University of Florida Foundation. The event served as a showcase for
why many feel UF has one of the most comprehensive biotechnology
research programs of any college or university in the country.
Attendees learned about the latest cutting-edge research taking
place in biomedical engineering, agricultural biotechnology,
genomics, veterinary medicine, and the
interface between biotechnology and nanotechnology, and were also
treated to presentations by some of the most promising biotech
startup companies coming out of
UF research.

Dr. Wayne Hockmeyer, a University of Florida alumnus who is
founder and chairman of one of the most successful biotech
companies in the nation--MedImmune, Inc.--served as honorary
chair and keynote speaker for the Corporate Leaders Summit. Dr.
Hockmeyer also is President of newly created MedImmune Ventures,
a $100 million biotech venture capital fund based at the company's
headquarters in Gaithersburg, Maryland.
Other industry participants in the Summit included:

Dr. Gail H. Cassell, Vice President for Scientific Affairs at
Eli Lilly and Company and a member of the Secretary of Health and
Human Services Advisory Council on Public Health Preparedness

David J. Gury, Chairman of the Board and CEO of Boca Raton-based

file:///F|/SHARE/Office%20of%20Technology%20Licens...ts/Sebastian/newsletter/newsletter/newsletter.html (1 of 5) [2/27/2003 4:28:42 PM]

Venture Newsletter

D Incu b r ,

* -. [2e l4'I--em -I 11
Sheld onS1 Scut Dirto rS

Dr. Wi fredM. Phil 1 ip

Res~eac & 6rdut rorm

PO Bo 11550


http://rgp uflSed

Th -FC Vetr e-neslete i
sen toyub teUieriyo

-Urd omriliainCucl

To be ~ re oe fro th -
Vetr maln lit plae.m i

Nabi Biopharmaceuticals and Chairman of the Florida Research
Consortium and BioFlorida

Dr. Ronald Evens, Managing Director, MAPS 4 Biotech and former
executive with Amgen Inc.

Sid Martin Biotechnology Development Incubator
Recognized as a Top-Performing Program

The Sid Martin Biotechnology Development Incubator (BDI), a division of the
Biotechnology Program at the University of Florida, has been ranked a top-performing
technology incubator in a report produced by the National Business incubation
Association (NBIA) following a 12-month analysis of U.S. Technology business
incubation programs.

In the recently concluded study, an industry research team organized by NBIA
examined the make-up and performance of technology incubators across the country to
determine the characteristics key to high-performing programs. Seventy-nine programs
participated in the study, which was funded by a grant from the U.S. Department of
Commerce's Office of Technology policy.

BDI was ranked in the top ten programs in the study in terms of average employment
growth achieved by client companies.

"The ultimate goal of an incubation program is to facilitate the business success of its
client companies," said Dinah Adkins, NBIA president and CEO. "The Sid Martin
Biotechnology Development Incubator has created a program that provides biotech
entrepreneurs with the resources they need to create high-growth enterprises, which has
benefited both the entrepreneurs and Florida's business community.
" Dr. Sheldon Schuster, Director of the Biotechnology Program at UF, said "While we
know that our entrepreneurs and staff are working hard to make this incubator a
success, it is gratifying to see it reflected in this national survey."

Business incubation programs catalyze the process of starting and growing companies
by providing entrepreneurs with the expertise, networks and toolls they need to make
their ventures successful. These programs help emerging businesses survive the risky
start-up phase by providing them with an array of business support services, such as
flexible leases and on-site business counseling, with a goal of graduating successful
firms that create jobs and build wealth in their communities.

Out of the 79 programs analyzed by NBIA, BDI ranked seventh in terms of average
employment growth of its client companies, fourth in terms average equity investment,
and first in terms of the amount of intellectual property that its client companies have
licensed into their operations. These impressive results reflect BDI's ongoing
commitment to its companies and to its surrounding community.

file:///F|/SHARE/Office%20of%20Technology%20Licens...ts/Sebastian/newsletter/newsletter/newsletter.html (2 of 5) [2/27/2003 4:28:42 PM]

Venture Newsletter

With about 950 members, the National Business Association is the world's leading
organization advancing business incubation and entrepreneurship. It provides
thousands of professionals with information, education, advocacy and networking
resources to bring excellence to the process of assisting early-stage companies. For
more information about business incubation or NBIA, visit www.nbia.org.

Return to top


Florida Research Universities Focus on INNOVATION at AUTM

file:///Fl/SHARE/Office%20of%20Technology%20Licens...ts/Sebastian/newsletter/newsletter/newsletter.html (3 of 5) [2/27/2003 4:28:42 PM]

Venture Newsletter

technology transfer representatives from the University of Florida
along with those from Florida's other research universities united
their efforts to show companies from across the nation that Florida is
about more than tourism. It was apparent to attendees at the recent
annual meeting of the Association of University Technology Managers
(AUTM), February 5, in Orlando, Florida, that the research and
technologies being created in Florida are providing the cutting-edge
technologies to develop start-ups or to create and expand product
lines within existing companies.
UF's Office of Technology Licensing led the collaborative effort to
host an "introduction to Florida's innovative technologies" event as
attendees arrived from around the globe for the annual AUTM 2003
meeting. With representatives, displays, and "Florida technology-
based" door prizes on hand, the University of Florida joined with
Florida A & M University, Florida Atlantic University, Florida State
University, University of Central Florida, University of Miami,
University of North Florida, University of South Florida, and
University of West Florida, to take advantage of this unique
opportunity for showcasing the commercially-oriented science
developed around the state. Sponsorship for the event was also
provided by Enterprise Florida, Inc. and Akerman Senterfitt & Eidson
With many industry leaders in attendance, the OTL team had the
opportunity to promote some of UF's newest research discoveries as
well as its success stories, while contributing to the overall goal of
focusing on technology innovation in the state of Florida.
Corporations attending included Astra Zeneca, L'Oreal, Aventis
Pharmaceuticals, Bristol-Myers Squibb Medical Imaging, Microsoft
Corp., GlaxoSmithKline, Amgen Inc., and Procter & Gamble

Return to top


Developments ans Start-ups

A $10 million proposal to develop a bio-processing facility in Alachua
was one of three that Florida's Emerging Technology Commission has
recommended for funding. The plan, submitted by the Unversity of
Florida, has been forwarded for review to the state Board of
Education. UF is negotiating with Regeneration Technologies Inc.
(RTI) in Alachua to purchase two of its former buildings for the bio-
processing facility. The ultimate goal of this project is to stimulate
promising research and commercialization of high potential
technologies that will provide treatments and cures for human
diseases in the area of Regenerative Health as well as create new
companies, high-wage jobs, and economic development for Florida.

file:///F|/SHARE/Office%20of%20Technology%20Licens...ts/Sebastian/newsletter/newsletter/newsletter.html (4 of 5) [2/27/2003 4:28:42 PM]

Venture Newsletter

Regenerative Health uses advanced medical approaches such as
gene therapy to repair genetic mutations, and transplantation of
adult stem cells to repair and restore damaged tissues and organs.
The two other plans chosen by the Emerging Technology Commission
were a biomedical and marine technology facility at Florida Atlantic
University, and the University of Central Florida's plan to establish a
center for photonics, or research using lasers and optical
The Sid Martin Biotechnology Incubator has two new companies:

EcoArray, L.L.C. was founded by John Rogers, with UFs Nancy
Denslow, Ph.D. and Patrick Larkin, Ph.D. in 2002. EcoArray combines
proprietary fish gene data and expertise in array construction to
develop products for environmental testing based on fish genes. The
company will be licensing UF technology, and has been awarded a
$400,000 two-year Phase I SBIR grant.

Encor Biotechnology, Inc. is an antibody development and
commercialization company founded by UF's Gerald Shaw, Ph.D. and
his business partner, William Gathings, Ph.D. The company's initial
focus will be on products for the biomedical research and diagnostic
pathology markets.

Check here for current listing of upcoming events:

Calendar of Events

file:///F|/SHARE/Office%20of%20Technology%20Licens...ts/Sebastian/newsletter/newsletter/newsletter.html (5 of 5) [2/27/2003 4:28:42 PM]

University of Florida Home Page
© 2004 - 2010 University of Florida George A. Smathers Libraries.
All rights reserved.

Acceptable Use, Copyright, and Disclaimer Statement
Last updated October 10, 2010 - - mvs